CompanyINCRNasdaqHerzliya, L3

Intercure Ltd.

InterCure (dba Canndoc) develops pharmaceutical-grade medical cannabis products in Israel.

SEC EDGAR ClinicalTrials.gov intercure.co

6-KSep 8Latest SEC filing, period to Sep 8

Aug 31Latest story

August 2026

Intercure files Form D covering equity issued for Botanico acquisition

Aug 19FinancingIntercure Ltd.